View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Michael Piccolo
  • Michael Piccolo

Daily Recap: TASK, STAA, CCRN, HZO, AES, RNA, ARKO, FUBO, BARK, SITM, ...

TaskUs, Inc. (TASK - $11.11)AI Pivot Underway, We Think Up to the TASK; Mike Piccolo Initiating Coverage at OUTPERFORM with $15 Price Target. We are initiating coverage on TASK with an OUTPERFORM rating and a price target of $15 per share as we believe shares represent an attractive risk/reward opp

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 13, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 8, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Edwards Lifesciences Corp: 3 directors

Three Directors at Edwards Lifesciences Corp sold/sold after exercising options/gave away 22,120 shares at between 0.000USD and 84.029USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretion...

Andy Hanson ... (+2)
  • Andy Hanson
  • Carl Smith

boohoo Group (DEBS LN) - Interim results – Marketplace transformation ...

Two years of transition can clearly be seen in Debenhams interim results with 30% of revenue now derived from marketplace. This asset light, cost light, high margin, cash generative model is a game changer in terms of the longer-term valuation. Whilst there is further work to be done, we see strong potential for the Group to deliver sustainable, profitable growth via its proprietary marketplace platform. Based on our forecasts, the shares trade on only 6.4x FY26 EV/EBITDA, falling to 5.2x in FY2...

Andy Hanson ... (+3)
  • Andy Hanson
  • Charlie Williams
  • Rachel Birkett

boohoo Group (DEBS LN) - FY25 results: Executing on turnaround - Corpo...

boohoo Group has released FY25 results to February year end showing significant progress against its multi-year strategy of turning the Group into a capital-lite, stock-lite, cost-lite, cash generative marketplace model. Group revenue and EBITDA were broadly in line with Zeus’ estimates (page 2), with net debt showing significant improvements since H1-25 of £78.2m vs £143.1m, following the equity raise and disposal of non-core assets. Today’s announcement also confirms the discontinuation of PLT...

Moody's Ratings affirms Edwards Lifesciences at Baa2; revises outlook ...

Moody's Ratings (Moody's) affirmed the ratings of Edwards Lifesciences Corporation (Edwards) including the Baa2 senior unsecured notes and Baa2 senior unsecured bank credit facilities. At the same time, we revised the outlook to positive from stable. The rating affirmation reflects our view that E...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: April 5, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: April 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 28, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch